يعرض 1 - 10 نتائج من 75 نتيجة بحث عن '"flucloxacillin/dt [Drug Therapy]"', وقت الاستعلام: 1.34s تنقيح النتائج
  1. 1

    المصدر: Jeppesen, S M, Frokjaer, J & Yderstraede, K 2015, ' Conservative treatment in a patient with diabetic osteomyelitis : Antibiotic treatment is sufficient for complete bone regeneration in selected cases ', BMJ Case Reports, vol. 2015 . https://doi.org/10.1136/bcr-2015-211376Test

  2. 2
    دورية أكاديمية

    المصدر: Jeppesen , S M , Frokjaer , J & Yderstraede , K 2015 , ' Conservative treatment in a patient with diabetic osteomyelitis : Antibiotic treatment is sufficient for complete bone regeneration in selected cases ' , BMJ Case Reports , vol. 2015 . https://doi.org/10.1136/bcr-2015-211376Test

  3. 3
    مورد إلكتروني
  4. 4
    مورد إلكتروني
  5. 5
    مورد إلكتروني
  6. 6
    مورد إلكتروني

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35361Test
    Journal of Paediatrics and Child Health
    Click here for full text options
    LibKey Link

  7. 7
    مورد إلكتروني

    مصطلحات الفهرس: vancomycin/iv [Intravenous Drug Administration], vancomycin/pv [Special Situation for Pharmacovigilance], daptomycin/iv [Intravenous Drug Administration], acute kidney failure/si [Side Effect], adult, aged, all cause mortality, article, clinical outcome, controlled study, diarrhea/si [Side Effect], drug efficacy, drug fever/si [Side Effect], drug monitoring, drug safety, female, follow up, general practitioner, hospitalization, human, hypertransaminasemia/si [Side Effect], major clinical study, male, methicillin resistant Staphylococcus aureus infection/dt [Drug Therapy], monotherapy, mortality rate, pilot study, priority journal, randomized controlled trial, rash/si [Side Effect], recurrent disease, therapy effect, thrombocytopenia/si [Side Effect], thrombophlebitis/si [Side Effect], treatment duration, treatment failure, cefazolin/ae [Adverse Drug Reaction], cefazolin/cb [Drug Combination], cefazolin/dt [Drug Therapy], cefazolin/iv [Intravenous Drug Administration], cefazolin/pv [Special Situation for Pharmacovigilance], cloxacillin/ae [Adverse Drug Reaction], cloxacillin/cb [Drug Combination], cloxacillin/dt [Drug Therapy], cloxacillin/iv [Intravenous Drug Administration], cloxacillin/pv [Special Situation for Pharmacovigilance], daptomycin/ae [Adverse Drug Reaction], daptomycin/cb [Drug Combination], daptomycin/dt [Drug Therapy], daptomycin/pv [Special Situation for Pharmacovigilance], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], flucloxacillin/pv [Special Situation for Pharmacovigilance], vancomycin/ae [Adverse Drug Reaction], vancomycin/cb [Drug Combination], vancomycin/dt [Drug Therapy], Article

    URL: JAMA - Journal of the American Medical Association
    Click here for full text options
    LibKey Link

  8. 8
    مورد إلكتروني
  9. 9
    مورد إلكتروني

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35361Test
    Journal of Paediatrics and Child Health
    LibKey Link

  10. 10
    مورد إلكتروني

    مصطلحات الفهرس: vancomycin/iv [Intravenous Drug Administration], vancomycin/pv [Special Situation for Pharmacovigilance], daptomycin/iv [Intravenous Drug Administration], acute kidney failure/si [Side Effect], adult, aged, all cause mortality, article, clinical outcome, controlled study, diarrhea/si [Side Effect], drug efficacy, drug fever/si [Side Effect], drug monitoring, drug safety, female, follow up, general practitioner, hospitalization, human, hypertransaminasemia/si [Side Effect], major clinical study, male, methicillin resistant Staphylococcus aureus infection/dt [Drug Therapy], monotherapy, mortality rate, pilot study, priority journal, randomized controlled trial, rash/si [Side Effect], recurrent disease, therapy effect, thrombocytopenia/si [Side Effect], thrombophlebitis/si [Side Effect], treatment duration, treatment failure, cefazolin/ae [Adverse Drug Reaction], cefazolin/cb [Drug Combination], cefazolin/dt [Drug Therapy], cefazolin/iv [Intravenous Drug Administration], cefazolin/pv [Special Situation for Pharmacovigilance], cloxacillin/ae [Adverse Drug Reaction], cloxacillin/cb [Drug Combination], cloxacillin/dt [Drug Therapy], cloxacillin/iv [Intravenous Drug Administration], cloxacillin/pv [Special Situation for Pharmacovigilance], daptomycin/ae [Adverse Drug Reaction], daptomycin/cb [Drug Combination], daptomycin/dt [Drug Therapy], daptomycin/pv [Special Situation for Pharmacovigilance], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], flucloxacillin/pv [Special Situation for Pharmacovigilance], vancomycin/ae [Adverse Drug Reaction], vancomycin/cb [Drug Combination], vancomycin/dt [Drug Therapy], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29372Test
    JAMA - Journal of the American Medical Association
    LibKey Link